Burns Matteson Capital Management LLC Makes New $768,000 Investment in Molina Healthcare, Inc $MOH

Burns Matteson Capital Management LLC acquired a new position in Molina Healthcare, Inc (NYSE:MOH) in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor acquired 4,425 shares of the company’s stock, valued at approximately $768,000.

A number of other large investors also recently modified their holdings of the stock. Miller Global Investments LLC bought a new stake in Molina Healthcare during the fourth quarter worth $27,000. Bogart Wealth LLC bought a new position in Molina Healthcare during the 3rd quarter valued at $39,000. CYBER HORNET ETFs LLC purchased a new position in Molina Healthcare during the 2nd quarter worth $45,000. SJS Investment Consulting Inc. boosted its holdings in Molina Healthcare by 6,225.0% during the 3rd quarter. SJS Investment Consulting Inc. now owns 253 shares of the company’s stock worth $48,000 after acquiring an additional 249 shares during the last quarter. Finally, MUFG Securities EMEA plc bought a new stake in shares of Molina Healthcare in the 2nd quarter worth $48,000. Institutional investors own 98.50% of the company’s stock.

Molina Healthcare Stock Performance

Shares of MOH opened at $133.13 on Wednesday. Molina Healthcare, Inc has a 1 year low of $121.06 and a 1 year high of $359.97. The company has a debt-to-equity ratio of 0.97, a current ratio of 1.69 and a quick ratio of 1.69. The stock’s fifty day moving average price is $152.60 and its two-hundred day moving average price is $163.73. The firm has a market cap of $6.94 billion, a PE ratio of 15.55 and a beta of 0.52.

Molina Healthcare (NYSE:MOH) last posted its quarterly earnings results on Thursday, February 5th. The company reported ($2.75) earnings per share for the quarter, missing the consensus estimate of $0.43 by ($3.18). Molina Healthcare had a return on equity of 13.60% and a net margin of 1.04%.The firm had revenue of $11.38 billion for the quarter, compared to the consensus estimate of $10.90 billion. During the same quarter in the previous year, the company posted $5.05 EPS. The firm’s revenue was up 8.3% compared to the same quarter last year. Molina Healthcare has set its FY 2026 guidance at 5.000- EPS. On average, equities research analysts forecast that Molina Healthcare, Inc will post 24.4 EPS for the current year.

Analyst Ratings Changes

MOH has been the topic of a number of recent analyst reports. Truist Financial dropped their price target on shares of Molina Healthcare from $190.00 to $145.00 and set a “hold” rating on the stock in a research report on Tuesday, February 17th. UBS Group set a $173.00 price objective on shares of Molina Healthcare in a research report on Friday, March 13th. Mizuho decreased their price objective on shares of Molina Healthcare from $220.00 to $180.00 and set an “outperform” rating for the company in a research note on Thursday, March 12th. TD Cowen dropped their target price on shares of Molina Healthcare from $175.00 to $144.00 and set a “hold” rating on the stock in a research report on Monday, February 9th. Finally, Cantor Fitzgerald cut their target price on Molina Healthcare from $180.00 to $144.00 and set a “neutral” rating on the stock in a research note on Monday, February 9th. Two analysts have rated the stock with a Buy rating, ten have given a Hold rating and two have issued a Sell rating to the company’s stock. According to MarketBeat, the company currently has a consensus rating of “Hold” and a consensus target price of $169.21.

Molina Healthcare Company Profile

Molina Healthcare, Inc is a managed care company specializing in government-sponsored health insurance programs. The company offers Medicaid managed care plans, Medicare Advantage and prescription drug plans, and individual Marketplace plans under the Affordable Care Act. Through an integrated care model, Molina emphasizes preventive and primary care services, care coordination, and disease management to improve health outcomes for its members.

The company traces its roots to the early 1980s, when Dr.